Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1Completed 1

Sponsor Class

INDUSTRY 8OTHER 5UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

S 1 (combination) 7Cisplatin 7Radiotherapy, Intensity-Modulated 5Paclitaxel 5Oxaliplatin 3Irinotecan 3Capecitabine 3titanium silicide 2raltitrexed 2nimotuzumab 2nabiximols 2Radiotherapy 2Radiation Dose Hypofractionation 2pegylated granulocyte colony-stimulating factor 1nedaplatin 1icaritin 1gimeracil 1anlotinib 1Trastuzumab 1Temozolomide 1Tegafur 1TP protocol 1Surgical Procedures, Operative 1Radiotherapy, Adjuvant 1Radiation 1Pharmaceutical Preparations 1Pemetrexed 1Ondansetron 1Methylene Blue 1Lidocaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × UNKNOWN × pegylated granulocyte colony-stimulating factor × Clear all
NCT02953730 2016-11-03

The Study on the Pharmacokinetics of PEG-rhG-CSF in Children and Adolescents

ChineseAMS

Phase 4 Completed
9 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡